Simposio internacional de Cardio-oncología
🗓️ Jueves 25 septiembre de 7:00-18:00 hrs
📍Centro Médico ABC campus observatorio
‼️GRATUITO
‼️ Modalidad híbrida
Regístrate aquí: 👇🏻
https://t.co/YKr6Ux9R63
@ABCcentromedico@andreagallardo
Patients who choose hybrid cardiac telerehabilitation (hCTR) are generally younger, fitter, and have a better QoL and mental health at the start of hCTR compared with those enrolling in centre-based CR. ➡️ https://t.co/swnYZEGoqZ
@EJPCEiC@AboyansV@SilCastelletti@PeroneFrancesco@andreagallardo
Social determinants of health are independently associated with all-cause, cardiovascular, and cancer mortality among cancer survivors but not among individuals without cancer. https://t.co/09i7oWcRTL
@EJPCEiC@AboyansV@SilCastelletti@PeroneFrancesco@andreagallardo
Adding ECG abnormalities to CVD risk models for people with T2D improves prediction accuracy by up to 8%
A simple, low-cost test with a big impact on personalized care🫀https://t.co/DmieTJKdoQ @AboyansV@SilCastelletti@PeroneFrancesco @Savvashad @andreagallardo@escardio
Adults with higher levels of albuminuria within the low range (UACR <30 mg/g) and no major cardiovascular risk factors have higher risks of cardiovascular and all-cause mortality 🩺
https://t.co/lINEvgNBBh
@escardio@AboyansV@SilCastelletti@PeroneFrancesco@andreagallardo
Multiple treatments are required to treat HoFH and management requires an individualised approach, with consideration given to the efficacy, safety, tolerability, and accessibility of each treatment 🩺💊 https://t.co/fLjrRFc3ve
@EJPCEiC@AboyansV@SilCastelletti@peronefrancesco@EAPCPresident@andreagallardo #cvprev #EAPC_ESC #EJPC
Results from the European observational SANTORINI study: lipid-lowering therapy use and achievement of risk-based lipid goals increased over 1-year follow-up particularly when combination LLT was used 💊🩺
https://t.co/zd1oXgWlX3
@EJPCEiC@AboyansV@SilCastelletti@peronefrancesco@EAPCPresident@andreagallardo #cvprev #EAPC_ESC #EJPC
📚 Predictive value of 8-year blood pressure measures in intracerebral haemorrhage risk over 5 years:
✏️ 12 398 participants
✏️ cumulative BP exposure was positively associated with subsequent 5-year risk of ICH
✏️ The cumBP could improve the risk reclassification of the conventional 5-year ICH risk prediction model https://t.co/gnZfrgh2YJ
@EJPCEiC@EAPCPresident #EJPC #cvprev #CVD #EAPC_ESC
Join us at the EAPC Congress in Milan 🇮🇹 (April 3-5, 2025) for the latest in cardiovascular prevention! 🫀
📅 Abstract deadline: Nov 21, 2024
💰 Early registration: Feb 3, 2025
Don't miss it!
👉 https://t.co/KyFDC5o0Gm #EAPC2025#cvprev
🚨 Cardiovascular deaths are projected to rise by 73% by 2050, driven by modifiable risk factors.
Urgent preventive measures are critical to reduce the global health burden 🫀
https://t.co/tds35UiHbx @escardio@AboyansV@SilCastelletti @Savvashad @andreagallardo@PeroneFrancesco
🏃🏻♀️ Even in advanced chronic kidney disease, exercise can reduce cardiovascular risk and improve quality of life 🫀 Any activity is better than no activity! 🏋🏻🚵🏻
Tailored, multidisciplinary programs are key 💪🏻 https://t.co/GampD65kIp